Clinical Trials Sponsored by C-TRIC

Total 904 results

Nova Biomedical
C-TRIC

Completed

Study of the Analytical Performance of ALLEGRO™ Instrument

Diabetes

United Kingdom
Hepa C

Completed

Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort

Hepatitis C

Spain
Hepa C

Completed

Effectiveness, Safety and Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks (3D8)

Hepatitis C Infection

Spain
Laval University
V Joseph; C Minville; C Rheaume

Recruiting

Impact of Estrogen + Estradiol Receptor Alpha Modulator Therapy on Oxidative Stress in Post-menopausal Women With and Without Sleep Apnea (Alpha MenoX)

Sleep Apnea | Oxidative Stress | Post Menopausal

Canada
C. R. Bard

Recruiting

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial (PREVENT)

Open Midline Laparotomy

United States, Germany, France, Belgium, Austria
C. R. Bard

Recruiting

Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae (AVPAS)

Arteriovenous Fistula

United States, Canada
L&C Bio

Active, not recruiting

Clinical Trial to Evaluate the Regeneration of Articular Cartilage Through Arthroscopy After MegaCarti® Application

Osteoarthritis, Knee

Korea, Republic of
C. R. Bard

Enrolling by invitation

Venclose digiRF System Post Market Study

Venous Reflux | Chronic Venous Insufficiency

United States
C. R. Bard

Enrolling by invitation

PureWick™ France and U.S. At-Home Pilot Study

Nocturnal Enuresis

United States, France
C. R. Bard

Completed

Caterpillar™ Arterial Embolization Device Post-Market Study (MONARCH)

Embolization, Therapeutic

United States
C. R. Bard

Completed

Male External Catheters' Comparison of Comfort and Efficacy (MECCE)

Non-invasive Urine Output Management

United States
L&C Bio

Active, not recruiting

Clinical Trial to Evaluate the Efficacy and Safety of MegaCarti® in Knee Cartilage Defects

Osteoarthritis, Knee

Korea, Republic of
C. R. Bard

Completed

A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries

Femoral Artery Occlusion | Femoral Artery Stenosis | Stenosis of Popliteal Arteries | Occlusion of Popliteal Arteries

China
C. R. Bard

Completed

CATERPILLAR™ Arterial Embolization Device Study (CHRYSALIS)

Embolization, Therapeutic

Australia, New Zealand
C. R. Bard

Completed

Korean Post-market Registry Assessing the Clinical Use and Safety of the Lutonix DCB in Femoropopliteal Arteries

Peripheral Artery Disease

Korea, Republic of
C. R. Bard

Completed

LEVANT 2 Safety Registry

Peripheral Artery Disease | Femoropopliteal Artery Occlusion | Femoropopliteal Stenosis

United States
C. R. Bard

Completed

Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter (SAFE-DCB)

Arterial Occlusive Diseases | Peripheral Arterial Disease | Peripheral Vascular Diseases

United States
C. R. Bard

Completed

Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Femoropopliteal Arteries (LEVANT 2)

Popliteal Artery Stenosis | Popliteal Artery Occlusion | Femoral Artery Occlusion | Femoral Artery Stenosis

United States, Germany, Belgium, Austria
C. R. Bard

Terminated

Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females (CONFIRM) (CONFIRM)

Popliteal Artery Stenosis | Popliteal Artery Occlusion | Femoral Artery Occlusion | Femoral Artery Stenosis

United States
C. R. Bard

Completed

Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon for Treatment of BTK Arteries (BTKRegistry)

Peripheral Artery Disease

Austria, Belgium, France, Switzerland, Germany, Italy, Greece, Spain, United Kingdom, Portugal, Saudi Arabia
C. R. Bard

Completed

Bard LifeStent and Lutonix DCB for Treatment of Long Lesions in Femoropopliteal Arteries

Peripheral Artery Disease

Germany, Greece, Poland
C. R. Bard

Completed

Lutonix® DCB for Treatment of Long Lesions in Femoropopliteal Arteries

Femoral Artery Occlusion | Femoral Arterial Stenosis

Belgium, Austria, France, Germany, Switzerland
C. R. Bard

Completed

Bard® LifeStent® Vascular Stent Delivery System Study

Peripheral Vascular Disease

Austria, Germany
C. R. Bard

Completed

AccuCath™ Intravenous (IV) Device Used by Vascular Access Team (VAT)

Vascular Access Complication

United States
C. R. Bard

Completed

Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery

Pulmonary Disease

United States
C. R. Bard

Completed

Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)

Female Stress Urinary Incontinence

United States
C. R. Bard

Completed

ViVEXX Carotid Revascularization Trial (VIVA)

Carotid Artery Stenosis
C. R. Bard

Terminated

Study of a Urethral Catheter Coated With Eluting Silver Salts (SUCCESS) (SUCCESS)

Catheterization

United States
C. R. Bard

Completed

A Prospective Study of the Performance of the Bard® LifeStent® Vascular Stent Systems (REALITY) (REALITY)

Peripheral Artery Disease

Germany
C. R. Bard

Terminated

Use and Safety of the LUTONIX® Drug Coated Balloon Catheter in Arteries of the Lower Extremity (LEG)

Peripheral Artery Disease

Malaysia, New Zealand, Canada
C. R. Bard

Completed

Post-Marketing Study to Assess Complication Rates of Oncology Patients With Ports and Peripheral IVs (VEINSFORLIFE)

PORTs/Peripheral IVs Complication Rates

United States
C. R. Bard

Withdrawn

Paclitaxel Coated PTA Balloons for Treatment of Dysfunctional AV Fistulae and Grafts (ACCESS)

Dysfunctional AV Graft | Dysfunctional AV Fistula

Austria, Germany
C. R. Bard

Completed

LEVANT I, The Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis (LEVANT I)

Arteriosclerosis | Atherosclerosis | Vascular Disease

Germany, Belgium
C. R. Bard

Completed

Crosser Enters The Right Arterial Lumen (CENTRAL)

Chronic Total Occlusion of Artery of the Extremities

United States
C. R. Bard

Completed

A Retrospective Study With Prospective Follow-Up of Laparoscopic Ventral Hernia Repair Utilizing the Bard Sepramesh IP Composite (Sepramesh)

Hernia

United States
C. R. Bard

Completed

Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon

Arterial Occlusive Diseases | Peripheral Arterial Disease | Peripheral Vascular Diseases

United States
C. R. Bard

Active, not recruiting

Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Arteries (PREVISION)

Peripheral Arterial Disease | Peripheral Artery Disease | Stenosis Artery

Australia, New Zealand, Singapore
C. R. Bard

Completed

Xen Matrix™ AB Surgical Graft in Ventral or Incisional Midline Hernias

Incisional Hernia

United States
C. R. Bard

Terminated

SHERLOCK 3CG™ Diamond Tip Confirmation System (MODUS II)

Bundle-Branch Block | Tachycardia | Atrioventricular Block | Atrial Flutter | Premature Ventricular Contraction | Premature Atrial Contraction | Indication for Peripheral Intravenous Catheterization | Premature Junctional Contraction

United States, Australia
C. R. Bard

Completed

NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study

Lung Cancer | Lung Tumor

United States
C. R. Bard

Completed

BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease (VERNACULAR)

Peripheral Vascular Disease | Venous Disease | May-Thurner Syndrome | Iliofemoral Occlusive Disease

United States, Australia, Germany, Ireland, Netherlands, Spain, United Kingdom
C. R. Bard

Completed

BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease (BOLSTER)

Peripheral Vascular Disease | Peripheral Artery Disease | Arterial Occlusive Disease

United States, Germany, New Zealand
C. R. Bard

Completed

Study of Phasix™ Mesh for VHWG Grade 3 Midline Hernia Repair

Hernia | Hernia, Abdominal | Hernia, Incisional

Belgium, Netherlands, Denmark, France, Italy, United Kingdom, Austria, Germany
C. R. Bard

Completed

LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)

Peripheral Artery Disease

United States, Germany, Belgium, Austria, Switzerland
C. R. Bard

Terminated

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM") (CONTINUUM)

Superficial Femoral Artery Stenosis

United States
C. R. Bard

Completed

A Prospective, Multicenter All Comers Study of Phasix Mesh for Ventral or Incisional Hernia Repair

Ventral Hernia | Incisional Hernia

United States
C. R. Bard

Completed

Comparison of AccuCath IV Catheter and Conventional IV Catheter in Interventional Radiology

Vascular Access Complications

United States
C. R. Bard

Completed

Prospective Feasibility Trial of AccuCath 2.25" Blood Control (BC) Placed in Difficult Access Patients in the Emergency Department

Vascular Access Complication

United States
C. R. Bard

Completed

A Clinical Evaluation of the Bard® Luminexx™ Iliac Stent and Delivery System (Luminexx)

Iliac Artery Occlusive Disease
C. R. Bard

Completed

FLAIR™ Delivery System Study (FLAIR DS)

Constriction, Pathologic

United States

Clinical Trials Sponsored by C-TRIC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations